Cancer Treatment News and Research

RSS

Researchers evaluate decision aids for patient's choice of localised prostate cancer treatment

Doctors strive to make treatment decisions together with their patients - but is the decision really shared? According to adjunct professor Kari Tikkinen, shared decision-making isn't easy, and clinicians need help. The international research group led by Tikkinen has studied the decision aids for treatment choice of localised prostate cancer

30 Mar 2015

NCCC at Dartmouth designated again as Comprehensive Cancer Center by NCI

The National Cancer Institute has renewed its Cancer Center Support Grant to Norris Cotton Cancer Center at Dartmouth, continuing NCCC's designation as a Comprehensive Cancer Center.

29 Mar 2015

UVA researchers develop compound that could lead to improved leukemia treatments

Researchers at the University of Virginia School of Medicine have developed a compound that delays leukemia in mice and effectively kills leukemia cells in human tissue samples, raising hopes that the drug could lead to improved treatments in people. The researchers call it an exciting "new paradigm" for treating leukemia.

26 Mar 2015

Research opens door to new prostate cancer treatment

Researchers from the Centenary Institute’s Origins of Cancer Program have discovered new links between nutrition and prostate cancer.

26 Mar 2015

Personalized gene therapy to fight against cancer

The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according to Kalorama Information. The healthcare market research publisher stated that gene therapies that are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor.

25 Mar 2015

Scientists establish scientific basis for scalp cooling that can ensure hair retention after cancer treatment

HAIR loss is one of the most distressing side-effects of cancer treatment and can even deter some patients from undergoing life-saving chemotherapy. But researchers at the University of Huddersfield are establishing the scientific basis for a rapidly-advancing scalp cooling technology that can ensure hair retention in a vast number of cases.

From Paxman 25 Mar 2015

DNA samples collected from tampons may help detect endometrial cancer

Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons. The new approach specifically examines DNA samples from vaginal secretions for the presence of chemical "off" switches — known as methylation — that can disable genes that normally keep cancer in check.

25 Mar 2015

Rigontec raises €4.8 million in second closing of Series A financing round

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, today announces it has raised €4.8 million in a second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor.

24 Mar 2015

Radiation treatment can be delayed after prostatectomy to prevent side effects, say studies

Important news for men receiving treatment for prostate cancer: Two new studies from the University of Virginia School of Medicine have upended the widely held view that it's best to delay radiation treatment as long as possible after the removal of the prostate in order to prevent unwanted side effects.

23 Mar 2015

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low, Sweet Twin and Necta, could do far more than just keep our waistlines trim. According to new research, this popular sugar substitute could potentially lead to the development of drugs capable of combating aggressive, difficult-to-treat cancers with fewer side effects.

23 Mar 2015

Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test

Genomic Health today announced the presentation of 11 studies with the Oncotype DX breast cancer test at the 14th St. Gallen Breast Cancer Conference in Vienna, Austria. Studies presented include results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost savings when the test is used in early stage breast cancer.

23 Mar 2015

Discovery may lead to new potential treatment for drug-resistant melanoma

In the last several years, targeted therapies - drugs that directly impact specific genes and proteins involved in the progression of cancer - have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer. Now, researchers at The Wistar Institute have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, and understanding this phenomenon may lead to a new melanoma target or prompt new designs of these treatments.

23 Mar 2015

Women who learn stress management techniques during breast cancer treatment have better quality of life

A new study shows that providing women with skills to manage stress early in their breast cancer treatment can improve their mood and quality of life many years later. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that women given the opportunity to learn stress management techniques during treatment may benefit well into survivorship.

23 Mar 2015

Chemical found in stinging nettles and ants could improve cancer drug

A cancer drug could be made 50 times more effective by a chemical found in stinging nettles and ants, new research finds.

20 Mar 2015

RNA molecule can be manipulated to generate more neurons from neural stem cells

A research team at UC San Francisco has discovered an RNA molecule called Pnky that can be manipulated to increase the production of neurons from neural stem cells.

20 Mar 2015

Scientists figure out how to turn Bucky-balls into Buckybombs

In 1996, a trio of scientists won the Nobel Prize for Chemistry for their discovery of Buckminsterfullerene - soccer-ball-shaped spheres of 60 joined carbon atoms that exhibit special physical properties.

20 Mar 2015

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.

17 Mar 2015

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

Kennedy Funding Financial LLC has completed a $3.5 million loan for Lifestyle Real Estate I, LP, announced Gregg Wolfer, COO of the Englewood Cliffs, NJ-based direct private lender. The borrower is an affiliate of Lifestyle Healthcare Group (LHG), and the collateral is a 10.31-acre tract of vacant land in Bensalem Twp., Bucks County, PA. LHG has received approval from the township for a $185 million medical office campus.

17 Mar 2015

Penn researchers find evidence of new culprit in colon cancer

Colon cancer is a heavily studied disease -- and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010.

17 Mar 2015

Endovascular aneurysm repair procedure can extend lives even in high-risk patients: Study

Minimally invasive surgery can prevent a fatal rupture of an abdominal aortic aneurysm.

17 Mar 2015

Cancer Treatment News and Research

Researchers evaluate decision aids for patient's choice of localised prostate cancer treatment

NCCC at Dartmouth designated again as Comprehensive Cancer Center by NCI

UVA researchers develop compound that could lead to improved leukemia treatments

Research opens door to new prostate cancer treatment

Personalized gene therapy to fight against cancer

Scientists establish scientific basis for scalp cooling that can ensure hair retention after cancer treatment

DNA samples collected from tampons may help detect endometrial cancer

Rigontec raises €4.8 million in second closing of Series A financing round

Radiation treatment can be delayed after prostatectomy to prevent side effects, say studies

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test

Discovery may lead to new potential treatment for drug-resistant melanoma

Women who learn stress management techniques during breast cancer treatment have better quality of life

Chemical found in stinging nettles and ants could improve cancer drug

RNA molecule can be manipulated to generate more neurons from neural stem cells

Scientists figure out how to turn Bucky-balls into Buckybombs

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

Penn researchers find evidence of new culprit in colon cancer

Endovascular aneurysm repair procedure can extend lives even in high-risk patients: Study

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News